litlas
Log inCreate account

Malcolm V. Brock

Active 2000–2025

60
Papers
19,385
Citations
51
h-index
58
i10-index

Citations

Citations per year for Malcolm V. Brock1948: 2 citations1971: 1 citations1993: 1 citations1997: 1 citations2000: 1 citations2002: 1 citations2003: 2 citations2004: 9 citations2005: 23 citations2006: 23 citations2007: 54 citations2008: 80 citations2009: 85 citations2010: 107 citations2011: 88 citations2012: 114 citations2013: 158 citations2014: 181 citations2015: 255 citations2016: 347 citations2017: 353 citations2018: 294 citations2019: 893 citations2020: 1,102 citations2021: 961 citations2022: 776 citations2023: 594 citations2024: 785 citations2025: 389 citations2026: 17 citations1949–1970: no citations, so these years are not shown1972–1992: no citations, so these years are not shown1994–1996: no citations, so these years are not shown1998–1999: no citations, so these years are not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,338 citing papers, 29.6% of this breakdownChina: 1,864 citing papers, 16.5% of this breakdownUnited Kingdom: 603 citing papers, 5.4% of this breakdownGermany: 490 citing papers, 4.3% of this breakdownItaly: 437 citing papers, 3.9% of this breakdownJapan: 435 citing papers, 3.9% of this breakdownFrance: 332 citing papers, 2.9% of this breakdownCanada: 322 citing papers, 2.9% of this breakdownSpain: 297 citing papers, 2.6% of this breakdownSouth Korea: 263 citing papers, 2.3% of this breakdownAustralia: 246 citing papers, 2.2% of this breakdownNetherlands: 239 citing papers, 2.1% of this breakdown
0%29.6%Other 21.4%

Institutions

Fields

  • Medicine49.9%
  • Biochemistry, Genetics and Molecular Biology40.8%
  • Immunology and Microbiology5.1%
  • Computer Science1%
  • Engineering0.8%
  • Neuroscience0.4%
  • Other2%

Topics

  • Cancer Immunotherapy and Biomarkers6.4%
  • Lung Cancer Treatments and Mutations6.4%
  • Cancer Genomics and Diagnostics5.1%
  • Epigenetics and DNA Methylation4.9%
  • Lung Cancer Research Studies3.8%
  • RNA modifications and cancer3.4%
  • Other70%

Coauthors

All papers

Open in search
  1. Comprehensive molecular profiling of lung adenocarcinoma

    Authors: Eric A. Collisson, Barry S. Taylor, Joshua D. Campbell, Angela N. Brooks, Alice H. Berger, Juliann Chmielecki, Gad Getz, Peter S. Hammerman, Bryan Hernandez, Carrie Sougnez, Andrew D. Cherniack, Mara Rosenberg, Matthew Meyerson, Stacey B. Gabriel, Kristian Cibulskis, Jaegil Kim, Chip Stewart, Lee Lichtenstein, Eric S. Lander, Michael S. Lawrence, Marcin Imielinski, Robert C. Onofrio, Travis Zack, Elena Helman, Chandra Sekhar Pedamallu, Jill Mesirov, Gordon Saksena, Steven E. Schumacher, Scott L. Carter, Levi Garraway, Rameen Beroukhim, Juok Cho, Daniel DiCara, David Heiman, Pei Lin, William Mallard, Douglas Voet, Hailei Zhang, Lihua Zou, Michael S. Noble, Nils Gehlenborg, Helga Thorvaldsdottir, Marc-Danie Nazaire, Jim Robinson, William Lee, Marc Ladanyi, Nikolaus Schultz, Ronglai Shen, William D. Travis, B. Arman Aksoy, Giovanni Ciriello, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, Venkatraman E. Seshan, Boris Reva, Rileen Sinha, S. Onur Sumer, Nils Weinhold, Chris Sander, Natasha Rekhtman, Maureen Zakowski, Valerie W. Rusch, David G. Beer, Leslie Cope, Ludmila Danilova, James G. Herman, Stephen B. Baylin, Peter Illei, Edward Gabrielson, James Shin, Beverly Lee, Kristen Rodgers, Dante Trusty, Malcolm V. Brock, Chad J. Creighton, David Wheeler, Li Ding, Ramaswamy Govindan, Cyriac Kandoth, Robert Fulton, Lucinda L. Fulton, Michael D. McLellan, Richard K. Wilson, Kai Ye, Catrina C. Fronick, Christopher A. Maher, Christopher A. Miller, Michael C. Wendl, Christopher Cabanski, Elaine Mardis, Mark A. Watson, Sandra McDonald, Bryan Meyers, Raju Kucherlapati, Angela Hadjipanayis, Eran Hodis, Semin Lee, Angeliki Pantazi, Xiaojia Ren and 210 more - Nature 2014 cited by 5,918

  2. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

    Authors: Justina X. Caushi, Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia, Boyang Zhang, Emily Han-Chung Hsiue, Brian J. Mog, Wenpin Hou, Sune Justesen, Richard L. Blosser, Ada Tam, Valsamo Anagnostou, Tricia R. Cottrell, Haidan Guo, Hok Yee Chan, Dipika Singh, Sampriti Thapa, Arbor G. Dykema, Poromendro Burman, Begum Choudhury, Luis Aparicio, Laurene S. Cheung, Mara Lanis, Zineb Belcaid, Margueritta El Asmar, Peter B. Illei, Rulin Wang, Jennifer Meyers, Kornel E. Schuebel, Anuj Gupta, Alyza Skaist, Sarah J. Wheelan, Jarushka Naidoo, Kristen A. Marrone, Malcolm V. Brock, Jinny S. Ha, Errol L. Bush, Bernard J. Park, Matthew J. Bott, David R. Jones, Joshua E. Reuss, Victor E. Velculescu, Jamie E. Chaft, Kenneth W. Kinzler, Shibin Zhou, Bert Vogelstein, Janis M. Taube, Matthew D. Hellmann, Julie R. Brahmer, Taha Merghoub, Patrick M. Forde, Srinivasan Yegnasubramanian, Hongkai Ji, Drew M. Pardoll, Kellie N. Smith - Nature 2021 cited by 547

  3. Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

    Authors: Valsamo Anagnostou, Kellie N. Smith, Patrick M. Forde, Noushin Niknafs, Rohit Bhattacharya, James R. White, Theresa Zhang, Vilmos Adleff, Jillian Phallen, Neha Wali, Carolyn Hruban, Violeta Beleva Guthrie, Kristen Rodgers, Jarushka Naidoo, Hyunseok Kang, William H. Sharfman, Christos Georgiades, Franco Verde, Peter B. Illei, Qing Kay Li, Edward Gabrielson, Malcolm V. Brock, Cynthia A. Zahnow, Stephen B. Baylin, Robert B. Scharpf, Julie R. Brahmer, Rachel Karchin, Drew M. Pardoll, Victor E. Velculescu - Cancer Discovery 2016 cited by 899

  4. Epigenetic therapy inhibits metastases by disrupting premetastatic niches

    Authors: Zhihao Lü, Jianling Zou, Shuang Li, Michael J. Topper, Yong Tao, Hao Zhang, Xi Jiao, Wenbing Xie, Xiangqian Kong, Michelle Vaz, Huili Li, Yi Cai, Limin Xia, Peng Huang, Kristen Rodgers, Beverly Lee, Joanne Riemer, Chi-Ping Day, Ray-Whay Chiu Yen, Ying Cui, Yujiao Wang, Yanni Wang, Weiqiang Zhang, Hariharan Easwaran, Alicia Hulbert, KiBem Kim, Rosalyn A. Juergens, Stephen C. Yang, Richard J. Battafarano, Errol L. Bush, Stephen Broderick, Stephen M. Cattaneo, Julie R. Brahmer, Charles M. Rudin, John Wrangle, Yuping Mei, Young J. Kim, Bin Zhang, Ken Kang‐Hsin Wang, Patrick M. Forde, Joseph B. Margolick, Barry D. Nelkin, Cynthia A. Zahnow, Drew M. Pardoll, Franck Housseau, Stephen B. Baylin, Lin Shen, Malcolm V. Brock - Nature 2020 cited by 337

  5. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

    Authors: Charles M. Rudin, Steffen Durinck, Eric Stawiski, John T. Poirier, Zora Modrušan, David S. Shames, Emily Anne Smith Bergbower, Yinghui Guan, James Shin, Joseph Guillory, Celina Sanchez Rivers, Catherine K. Foo, Deepali Bhatt, Jeremy Stinson, Florian Gnad, Peter M. Haverty, Robert Gentleman, Subhra Chaudhuri, Vasantharajan Janakiraman, Bijay S. Jaiswal, Chaitali Parikh, Wenlin Yuan, Zemin Zhang, Hartmut Koeppen, Thomas D. Wu, Howard M. Stern, Robert L. Yauch, Kenneth E. Huffman, Diego D’Ávila Paskulin, Peter B. Illei, Marileila Varella‐Garcia, Adi F. Gazdar, Frédéric J. de Sauvage, Richard Bourgon, John D. Minna, Malcolm V. Brock, Somasekar Seshagiri - Nature Genetics 2012 cited by 1,098

  6. Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

    Authors: Valsamo Anagnostou, Patrick M. Forde, James R. White, Noushin Niknafs, Carolyn Hruban, Jarushka Naidoo, Kristen A. Marrone, I.K. Ashok Sivakumar, Daniel C. Bruhm, Samuel Rosner, Jillian Phallen, Alessandro Leal, Vilmos Adleff, Kellie N. Smith, Tricia R. Cottrell, Lamia Rhymee, Doreen N. Palsgrove, Christine L. Hann, Benjamin Levy, Josephine Feliciano, Christos Georgiades, Franco Verde, Peter B. Illei, Qing Kay Li, Edward Gabrielson, Malcolm V. Brock, James M. Isbell, Jennifer L. Sauter, Janis M. Taube, Robert B. Scharpf, Rachel Karchin, Drew M. Pardoll, Jamie E. Chaft, Matthew D. Hellmann, Julie R. Brahmer, Victor E. Velculescu - Cancer Research 2018 cited by 314

  7. Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer

    Authors: Anju Singh, Vikas Misra, Rajesh K. Thimmulappa, Hannah Lee, Stephen Ames, Mohammad Obaidul Hoque, James G. Herman, Stephen B. Baylin, David Sidransky, Edward Gabrielson, Malcolm V. Brock, Shyam Biswal - PLoS Medicine 2006 cited by 1,047

  8. Epidemiology of Lung Cancer

    Authors: Anthony J. Alberg, Malcolm V. Brock, Jean G. Ford, Jonathan M. Samet, Simon D. Spivack - CHEST Journal 2013 cited by 732

  9. Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer

    Authors: Rosalyn A. Juergens, John Wrangle, Frank P. Vendetti, Sara C. Murphy, Ming Zhao, Barbara Coleman, Rosa Sebree, Kristen Rodgers, Craig M. Hooker, Noreli Franco, Beverly Lee, Salina Tsai, Igor Espinoza Delgado, Michelle A. Rudek, Steven A. Belinsky, James G. Herman, Stephen B. Baylin, Malcolm V. Brock, Charles M. Rudin - Cancer Discovery 2011 cited by 680

  10. Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

    Authors: Valsamo Anagnostou, Noushin Niknafs, Kristen A. Marrone, Daniel C. Bruhm, James R. White, Jarushka Naidoo, Karlijn Hummelink, Kim Monkhorst, Ferry Lalezari, Mara Lanis, Samuel Rosner, Joshua E. Reuss, Kellie N. Smith, Vilmos Adleff, Kristen Rodgers, Zineb Belcaid, Lamia Rhymee, Benjamin Levy, Josephine Feliciano, Christine L. Hann, David S. Ettinger, Christos Georgiades, Franco Verde, Peter B. Illei, Qing Kay Li, Alexander S. Baras, Edward Gabrielson, Malcolm V. Brock, Rachel Karchin, Drew M. Pardoll, Stephen B. Baylin, Julie R. Brahmer, Robert B. Scharpf, Patrick M. Forde, Victor E. Velculescu - Nature Cancer 2020 cited by 207

  11. Prediction of lung cancer risk at follow-up screening with low-dose CT: a training and validation study of a deep learning method

    Authors: Peng Huang, Cheng Ting Lin, Yuliang Li, Martin C. Tammemägi, Malcolm V. Brock, Sukhinder Atkar-Khattra, Yanxun Xu, Ping Hu, John R. Mayo, Heidi Schmidt, Michel Gingras, Sergio Pasian, Lori Stewart, Scott Tsai, Jean M. Seely, Daria Manos, Paul Burrowes, Rick Bhatia, Ming‐Sound Tsao, Stephen Lam - The Lancet Digital Health 2019 cited by 144

  12. Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

    Authors: Joshua E. Reuss, Valsamo Anagnostou, Tricia R. Cottrell, Kellie N. Smith, Franco Verde, Marianna Zahurak, Mara Lanis, Joseph C. Murray, Hok Yee Chan, Caroline G. McCarthy, Daphne Wang, James R. White, Stephen C. Yang, Richard J. Battafarano, Stephen Broderick, Errol L. Bush, Malcolm V. Brock, Jinny S. Ha, David R. Jones, Taha Merghoub, Janis M. Taube, Victor E. Velculescu, Gary L. Rosner, Peter B. Illei, Drew M. Pardoll, Suzanne L. Topalian, Jarushka Naidoo, B.I. Levy, Matthew D. Hellmann, Julie R. Brahmer, Jamie E. Chaft, Patrick M. Forde - Journal for ImmunoTherapy of Cancer 2020 cited by 163

  13. Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells

    Authors: Hsing-Chen Tsai, Huili Li, Leander Van Neste, Yi Cai, Carine Robert, Feyruz V. Rassool, James Shin, Kirsten Harbom, Robert M. Beaty, Emmanouil P. Pappou, James Harris, Ray-Whay Chiu Yen, Nita Ahuja, Malcolm V. Brock, Vered Stearns, David Feller‐Kopman, Lonny Yarmus, Yi‐Chun Lin, Alana L. Welm, Jean‐Pierre J. Issa, Il Minn, William Matsui, Yoon-Young Jang, Saul J. Sharkis, Stephen B. Baylin, Cynthia A. Zahnow - Cancer Cell 2012 cited by 647

  14. Addition of Low-Dose Decitabine to Anti–PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma

    Authors: Jing Nie, Chunmeng Wang, Yang Liu, Qingming Yang, Qian Mei, Liang Dong, Xiang Li, Jiejie Liu, Wenjing Ku, Yan Zhang, Meixia Chen, Xiaojing An, Lu Shi, Malcolm V. Brock, Jie Bai, Weidong Han - Journal of Clinical Oncology 2019 cited by 222

  15. Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors

    Authors: Stuart A. Grossman, Susannah G. Ellsworth, Jian Campian, Aaron T. Wild, Joseph M. Herman, Dan Laheru, Malcolm V. Brock, Ani Sarkis Balmanoukian, Xiaobu Ye - Journal of the National Comprehensive Cancer Network 2015 cited by 322

  16. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum

    Authors: Alicia Hulbert, Ignacio Jusué-Torres, Alejandro Stark, Chen Chen, Kristen Rodgers, Beverly Lee, Candace Griffin, Andrew Yang, Peng Huang, John Wrangle, Steven A. Belinsky, Tza‐Huei Wang, Stephen C. Yang, Stephen B. Baylin, Malcolm V. Brock, James G. Herman - Clinical Cancer Research 2016 cited by 292

  17. Added Value of Computer-aided CT Image Features for Early Lung Cancer Diagnosis with Small Pulmonary Nodules: A Matched Case-Control Study

    Authors: Peng Huang, Seyoun Park, Rongkai Yan, Junghoon Lee, Linda C. Chu, Cheng Ting Lin, Amira Hussien, Joshua M. Rathmell, Brett Thomas, Chen Chen, Russell K. Hales, David S. Ettinger, Malcolm V. Brock, Ping Hu, Elliot K. Fishman, Edward Gabrielson, Stephen Lam - Radiology 2017 cited by 182

  18. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer

    Authors: Bin Liu, Julio Ricarte Filho, Apurva Mallisetty, Cassandra Villani, Αναστασία Κοττόρου, Kristen Rodgers, Chen Chen, Tomoaki Ito, Kyla Holmes, Nicole Gastala, Klara Valyi‐Nagy, Odile David, Ron C. Gaba, Christian Ascoli, Mary Pasquinelli, Lawrence Feldman, Malek G. Massad, Tza‐Huei Wang, Ignacio Jusué-Torres, Enrico Benedetti, Robert A. Winn, Malcolm V. Brock, James G. Herman, Alicia Hulbert - Clinical Cancer Research 2020 cited by 102

  19. Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier

    Authors: Zhihao Lü, Huan Chen, Xi Jiao, Wei Zhou, Wenbo Han, Shuang Li, Chang Liu, Jifang Gong, Jian Li, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanyan Li, Jie Li, Yan Li, Malcolm V. Brock, Henghui Zhang, Lin Shen - Journal for ImmunoTherapy of Cancer 2020 cited by 56

  20. Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma

    Authors: Yang Liu, Chunmeng Wang, Xiang Li, Liang Dong, Qingming Yang, Meixia Chen, Fengxia Shi, Malcolm V. Brock, Miao Liu, Qian Mei, Jiejie Liu, Jing Nie, Weidong Han - Journal for ImmunoTherapy of Cancer 2021 cited by 69

  21. Alterations of immune response of non-small cell lung cancer with Azacytidine

    Authors: John Wrangle, Wei Wang, Alexander Koch, Hariharan Easwaran, Helai P. Mohammad, Xiaoyu Pan, Frank P. Vendetti, Wim VanCriekinge, Timothy DeMeyer, Zhengzong Du, Princy Parsana, Kristen Rodgers, Ray-Whay Chiu Yen, Cynthia A. Zahnow, Janis M. Taube, Julie R. Brahmer, Scott S. Tykodi, Keith Easton, Richard D. Carvajal, Peter A. Jones, Peter W. Laird, Daniel J. Weisenberger, Salina Tsai, Rosalyn A. Juergens, Suzanne L. Topalian, Charles M. Rudin, Malcolm V. Brock, Drew M. Pardoll, Stephen B. Baylin - Oncotarget 2013 cited by 389

  22. The use of “overall accuracy” to evaluate the validity of screening or diagnostic tests

    Authors: Anthony J. Alberg, Ji Wan Park, Brant W. Hager, Malcolm V. Brock, Marie Diener‐West - Journal of General Internal Medicine 2004 cited by 300

  23. Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer

    Authors: Tianyun Jiang, Brendan Collins, Ning Jin, D. Neil Watkins, Malcolm V. Brock, William Matsui, Barry D. Nelkin, Douglas W. Ball - Cancer Research 2009 cited by 190

  24. DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer

    Authors: Malcolm V. Brock, Craig M. Hooker, Emi Ota-Machida, Yu Han, Mingzhou Guo, Stephen Ames, Sabine C. Glöckner, Steven Piantadosi, Edward Gabrielson, Genevieve Pridham, Kristen Pelosky, Steven A. Belinsky, Stephen C. Yang, Stephen B. Baylin, James G. Herman - New England Journal of Medicine 2008 cited by 603